Skip to main content
. 2020 Sep 17;19(7):1469–1479.e19. doi: 10.1016/j.cgh.2020.09.027

Supplementary Figure 4.

Supplementary Figure 4

Comorbidities in patients with CLD and COVID-19. (A) Clinical severity of patients with CLD and COVID-19 CLD stratified by comorbidities that affect cardiovascular health. (B) Clinical severity of patients with CLD and COVID-19 stratified by comorbidities that affect pulmonary health. Graph shows the percentage of patients with a specific comorbidity who had these outcomes. Significance determined by comparing clinical outcomes in patients with (shown) vs those without (not shown) the specific comorbidity. CAD, coronary artery disease; CHF, congestive heart failure; CLD, chronic liver disease; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; DM, diabetes mellitus; HLD, hyperlipidemia; HTN, hypertension; ICU, intensive care unit; OSA, obstructive sleep apnea. ∗indicates a significantly higher proportion. ∗P < .05; ∗∗P < 0.01; ∗∗∗P < .001; ∗∗∗∗P < .0001; ∗∗∗∗∗P < .00001.